Following AstraZeneca's acknowledgment in a UK court that its Covid-19 vaccine triggered a rare side effect—Thrombosis with Thrombocytopenia Syndrome (TTS), Hyderabad-based vaccine manufacturer Bharat Biotech emphasized the safety of its indigenous vaccine, Covaxin, aiming to alleviate public apprehensions regarding Covid vaccines.
Friday, May 03, 2024
Bharat Biotech stresses on Covaxin’s safety record after AstraZeneca admits to Covishield causing rare clotting side effects
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment